Sunday, February 10, 2013

Aldosterone receptor antagonists in heart failure management

Here is a superb update in CCJM. These things are clear:

The indications for the use of ARAs in heart failure are expanding since the publication of RALES.

ARAs are underutilized.

When they are used patients are not monitored well enough for hyperkalemia.

No comments: